A new possible vaccine candidate to fight the COVID-19 pandemic

This week the race for a long-awaited vaccine proceeded somewhat further as the joint mega collaboration effort between AstraZeneca and the University of Oxford instilled new hope for the medical community and the world as its vaccine trial was given the go-ahead by the MHRA (Medicines Health Regulatory Authority) after being halted by reports of a severe immune reaction in a volunteer.

The vaccine, known as AZD1222, is one of the first to reach the Stage 3 trial phase of what is a long and technical process filled with uncertainty. The World Health Organization has cited AZD1222, a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus that contains the genetic material of the SARS-CoV-2 virus spike protein.

Phases of a vaccine trial

- Advertisement -

With the hundreds of vaccine candidates in the race for a final vaccine against the coronavirus, we attempt to break down the headache, inducing “stages” of a trial.

Before going on to the manufacturing stage, a vaccine trial contains three significant phases.

Read Also: New research suggests link between genes and COVID-19 infection

The first phase includes an attempt to assess the candidate vaccine in humans involves a small group of adults, usually between 20-80 subjects. If the vaccine is intended for children, researchers will first test adults, and then gradually step down the age of the test subjects. 

- Advertisement -

A larger group of several hundred individuals participates in Phase II testing. Some of the individuals may belong to groups at risk of acquiring the disease. Successful Phase II candidate vaccines move on to larger trials, involving thousands to tens of thousands of people. These Phase III tests are randomized and double-blind, even involving the experimental vaccine being tested against a placebo.

Do you want to publish on Apple News, Google News, and more? Join our writing community, improve your writing skills, and be read by hundreds of thousands around the world!

Source: The History Of Vaccines

More from Health – News Landed

+ The next penicillin? Fungi-based drug startup ‘Hexagon Bio’ raises $47 million
+ Flu shots may also help in the fight against COVID-19

Popular Stories – News Landed

- Advertisement -

+ Yoshihide Suga: Japan’s newest PM, succeeding Shinzo Abe
+ The Russian space agency says ‘Venus is a Russian planet’ while announcing a new mission

Related Stories

Daily use of aspirin can lower the risk of COVID-19 death, study finds

A new study reveals that patients hospitalized for COVID-19 that take aspirin daily (low dosage) have a...

The COVID-19 mortality rate may rise during the winter

The mortality rate due to COVID-19 is going to rise significantly at the time of the winter...

Featured Stories

Match 46 Oct 26: KXIP win and make the points table even more interesting

It's match 46 in the IPL, and it's a big match today. KKR takes on KXIP for...

NASA to announce exciting discovery about Moon

On October 26, at 12 PM EDT NASA will announce an exciting discovery about Moon from the...

Daily use of aspirin can lower the risk of COVID-19 death, study finds

A new study reveals that patients hospitalized for COVID-19 that take aspirin daily (low dosage) have a...

The peer pressure of a medical dream in India

If you are either born, studying, or working in India, you pretty much should have come across...

Venus: 10 shocking facts about our nearest planet you never knew

1. A day on Venus is longer than its year. It takes 243 Earth...

Comment Below

Daily use of aspirin can lower the risk of COVID-19 death, study finds

A new study reveals that patients hospitalized for COVID-19 that take aspirin daily (low dosage) have a...

The COVID-19 mortality rate may rise during the winter

The mortality rate due to COVID-19 is going to rise significantly at the time of the winter...